Which Danish pharmaceutical company makes Ozempic and Wegovy?

Novo Nordisk makes Ozempic and Wegovy, medicines whose active ingredient is semaglutide.

Novo Nordisk is a Danish pharmaceutical company formed in 1989 through the merger of Novo Industri and Nordisk Gentofte. Its history is closely linked to diabetes care, especially insulin and other treatments that help regulate blood glucose.

Ozempic is marketed for adults with type 2 diabetes, while Wegovy is a higher-dose semaglutide product approved for chronic weight management in eligible patients. Both medicines belong to the GLP-1 receptor agonist class, which affects blood sugar regulation and appetite.

Novo Nordisk is often confused with Eli Lilly because Eli Lilly makes the competing medicines Mounjaro and Zepbound, which use tirzepatide rather than semaglutide. Demand for GLP-1 medicines became a major factor in Novo Nordisk’s rapid rise in market value.